Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Grant Revenue	$ 314,890		$ 824,205
Operating Expenses:
Research and development	580,390	608,653	2,068,154	1,866,776
General and administrative	400,689	438,578	1,500,278	1,583,148
Total Operating Expenses	981,079	1,047,231	3,568,432	3,449,924
Total Operating Loss	(666,189)	(1,047,231)	(2,744,227)	(3,449,924)
Other Income/(Expense):
Research and development tax (deficit)/credit	(638)	(507)	37,621	31,637
Gain from extinguishment				63,094
Interest expense, net	(46,440)	(3,521)	(115,424)	(945,607)
Total Other Expense, Net	(47,078)	(4,028)	(77,803)	(850,876)
Net Loss	$ (713,267)	$ (1,051,259)	$ (2,822,030)	$ (4,300,800)
Basic and Diluted Loss Per Common Share	$ (0.00)	$ (0.00)	$ (0.01)	$ (0.01)
Weighted Average Number of Common Shares Outstanding - Basic and Diluted	419,489,239	409,961,614	419,461,313	405,286,784